We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma (TRACC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00827671
Recruitment Status : Terminated (Experimental treatment not feasible due to high rate of drop out)
First Posted : January 23, 2009
Last Update Posted : October 27, 2010
Sponsor:
Collaborator:
Merck KGaA
Information provided by:
UMC Utrecht